| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/22/1995 | WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/22/1995 | WO1995014781A3 Methods for diagnosing early lyme disease |
| 06/22/1995 | WO1995014780A3 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies |
| 06/22/1995 | WO1995013386A3 Tyrosinase-activator protein fusion enzyme |
| 06/22/1995 | WO1995009241A3 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 06/22/1995 | WO1995007987A3 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 06/22/1995 | EP0665883A4 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals. |
| 06/22/1995 | DE4419264A1 Antigen, um Menschen und Tieren eine schützende Immunität gegen Wurminfektionen zu verleihen To confer antigen humans and animals protective immunity against worm infections |
| 06/22/1995 | DE4342769A1 Isolation and cloning of cDNA encoding RNA binding protein (RBP) |
| 06/22/1995 | CA2179285A1 Compositions and methods relating to dna mismatch repair genes |
| 06/22/1995 | CA2179149A1 Methods and materials for the detection of staphylococcus aureus |
| 06/22/1995 | CA2179018A1 Method for antigen-specific immunoregulation by t-cell alpha chain |
| 06/22/1995 | CA2178965A1 Origin of replication complex genes, proteins and methods |
| 06/22/1995 | CA2178218A1 Analogues of hgh-rh (1-29)nh2 having antagonistic activity |
| 06/22/1995 | CA2177269A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 06/22/1995 | CA2155930A1 Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby |
| 06/22/1995 | CA2155929A1 Systemic gene treatment of connective tissue diseases |
| 06/22/1995 | CA2155844A1 Antiviral composition of viral protein trans-dominant variants |
| 06/22/1995 | CA2155568A1 Human interferon expression vectors for treating aids |
| 06/22/1995 | CA2138605A1 Immunoreactive peptides of apo(a) |
| 06/21/1995 | EP0658627A2 Recombinant DNA with interferon-alpha promoter |
| 06/21/1995 | EP0658626A1 Methods for producing protein C |
| 06/21/1995 | EP0658625A2 Protein that can be biotinylated to be used for the germination stage determination |
| 06/21/1995 | EP0658624A2 Recombinant genes expressing pp14 |
| 06/21/1995 | EP0658623A2 Attenuated herpesviruses, herpesviruses which include foreign DNA encoding an amino acid sequence and vaccines containing same |
| 06/21/1995 | EP0658622A2 Fungi resistant to soraphen A |
| 06/21/1995 | EP0658569A1 Method for decoloring human serum albumin |
| 06/21/1995 | EP0658568A1 Glucagon-like insulinotropic peptides, compositions and methods |
| 06/21/1995 | EP0658567A1 Complexes between lectins and glycoproteins |
| 06/21/1995 | EP0658564A1 Electroluminescent compounds and intermediates in their synthesis |
| 06/21/1995 | EP0658345A1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 06/21/1995 | EP0658227A1 Paper strengthened with solubilized collagen, and method for making the same |
| 06/21/1995 | EP0658210A1 Translocation signal facilitated nuclear delivery of macromolecules |
| 06/21/1995 | EP0658208A1 Novel plants and processes for obtaining them |
| 06/21/1995 | EP0658205A1 Lipoprotein associated phospholipase a 2?, inhibitors thereof and use of the same in diagnosis and therapy |
| 06/21/1995 | EP0658201A1 Dna sequences involved in the secondary metabolite biosynthesis by myxobacteria |
| 06/21/1995 | EP0658200A1 Glucagon receptors |
| 06/21/1995 | EP0658199A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
| 06/21/1995 | EP0658198A1 Multicistronic expression units and their use |
| 06/21/1995 | EP0658196A1 GENE INSERTION BY DIRECT LIGATION $i(IN VITRO) |
| 06/21/1995 | EP0658170A1 Glucagon antagonists and methods for detecting glucagon antagonists |
| 06/21/1995 | EP0658169A1 Diamino acid derivatives as antihypertensives |
| 06/21/1995 | EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 06/21/1995 | EP0658120A1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 06/21/1995 | EP0658119A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
| 06/21/1995 | EP0658117A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 06/21/1995 | EP0658116A1 Methods useful in endotoxin prophylaxis and therapy |
| 06/21/1995 | EP0658115A1 Peptide medicaments for treating disease |
| 06/21/1995 | EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 06/21/1995 | EP0517831B1 Recovery of protein, protein isolate and/or starch from cereal grains |
| 06/21/1995 | EP0511970B1 Method for preparing an enzymatic hydrolyzate |
| 06/21/1995 | EP0458959B1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
| 06/21/1995 | EP0411105B1 Bone collagen matrix for implants |
| 06/21/1995 | CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition |
| 06/20/1995 | US5426181 DNA encoding cytokine-induced protein, TSG-14 |
| 06/20/1995 | US5426177 Ciliary neurotrophic factor receptor |
| 06/20/1995 | US5426103 Certain macrocyclic lactam derivatives |
| 06/20/1995 | US5426100 Therapeutic uses including antitumor agents, anticoagulants and wound healing agents |
| 06/20/1995 | US5426099 Process for inducing analgesia, peptides and therapeutic compositions |
| 06/20/1995 | US5426097 Calreticulin: a novel antithrombotic agent |
| 06/20/1995 | US5426051 Plasmid containing gene and expression control region for the gene, for homologous recombination with vaccinia virus |
| 06/20/1995 | US5426049 PS176 gene encoding nematode-active toxin cloned from a bacillus thuringiensis isolate |
| 06/20/1995 | US5426048 DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor |
| 06/20/1995 | US5426044 Minactivin compositions and antibodies to minactivin |
| 06/20/1995 | US5426036 Processes for the preparation of foreign proteins in streptomycetes |
| 06/20/1995 | US5426031 Extraction methods for preparing thromboplastin reagents |
| 06/20/1995 | US5426028 Testing sample of peripheral mononuclear cell, evaluating sample for CD11b, CD38 and antigen HLA-DR, by combining it with an immunophenotypic panel comprising atleast one antibody and analyzing |
| 06/20/1995 | US5425936 Useful for therapeutic, prophylactic and diagnostic purposes |
| 06/20/1995 | CA2000114C Melanin production |
| 06/20/1995 | CA1336034C Biodegradable polypeptide and the use thereof for the gradual release of drugs |
| 06/20/1995 | CA1335965C Cucumber mosaic virus coat protein gene |
| 06/18/1995 | CA2138349A1 Method for decoloring human serum albumin |
| 06/16/1995 | CA2138101A1 Methods for producing protein c |
| 06/16/1995 | CA2137120A1 Recombinant dna and transformant containing the same |
| 06/15/1995 | WO1995016206A1 Composition and method for detection of analytes |
| 06/15/1995 | WO1995016202A1 Labelling of nucleic acid analogue-peptide chimerae |
| 06/15/1995 | WO1995016051A2 Methods and compositions for the suppression of neu mediated transformation |
| 06/15/1995 | WO1995016048A2 Recombinant protein production in bovine adenovirus expression vector system |
| 06/15/1995 | WO1995016045A1 Construction of pasteurella heamolytica vaccines |
| 06/15/1995 | WO1995016044A2 Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules |
| 06/15/1995 | WO1995016040A2 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
| 06/15/1995 | WO1995016039A1 Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof |
| 06/15/1995 | WO1995016036A2 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF |
| 06/15/1995 | WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 06/15/1995 | WO1995016034A1 Mutants of bone morphogenetic proteins |
| 06/15/1995 | WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
| 06/15/1995 | WO1995016030A1 Purification of vitamin-k dependent proteins by membrane chromatography |
| 06/15/1995 | WO1995016027A1 Method of selecting specific bacteriophages |
| 06/15/1995 | WO1995015981A1 Compositions and kits for fluorescence polarization assay of large molecules |
| 06/15/1995 | WO1995015980A1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome |
| 06/15/1995 | WO1995015979A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015978A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015976A1 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
| 06/15/1995 | WO1995015975A1 Biologically active compounds |
| 06/15/1995 | WO1995015974A1 Protecting nucleic acids and methods of analysis |
| 06/15/1995 | WO1995015973A1 Cs-1 peptidomimetics, compositions and methods of using the same |
| 06/15/1995 | WO1995015972A1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 06/15/1995 | WO1995015767A1 Long-acting injection suspensions and a process for their preparation |
| 06/15/1995 | WO1995015765A1 Peptides to overcome inhibition of nerve growth |
| 06/15/1995 | WO1995015764A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |